Collectively, there is reason to consider HIF-1 signaling and autophagy as therapeutic targets of HDAC6i for atp6v0e1–/– or rd10 related blindness, but with potential applicability to a wider cohort of IRD and AMD patients. The gene discussed is HIF1A; the disease is blindness (disorder).